Show metadata Hide metadata

(19)

(11)

2 783 498

(13)

(51)

IPC

A61K31/7076(2006-01-01)

A61P9/00(2006-01-01)

(21) (22)

Application

2018143953, 2017-05-23

(24)

Start date

2017-05-23

(22)

Actual filing date

2017-05-23

(45)

Published

2022-11-14

(72)

Inventor

Zhu, HaiboWang, Minjie

(73)

Holder

Beijng Gushen Life Health Technology Co., Ltd.Institute Of Materia Medica, Chinese Academy Of Medical Sciences

METHODS FOR USE OF TRIACETYL-3-HYDROXYPHENYLADENOZINE IN TREATMENT OF INFLAMMATORY PROCESSES IN VESSELS OR IMPROVEMENT OF VESSEL ENDOTHELIUM FUNCTIONS Russian patent published in 2022 - IPC A61K31/7076 A61P9/00

Abstract RU 2783498 C2

FIELD: medicine; cardiology.

SUBSTANCE: group of inventions relates to medicine, namely to cardiology; it can be used for inhibition of leucocyte adhesion. The use, according to the invention, concerns triacetyl-3-hydroxyphenyladenozine. A pharmaceutical composition for the production of drugs for inhibition of leucocyte adhesion contains triacetyl-3-hydroxyphenyladenozine and a pharmaceutically acceptable carrier.

EFFECT: use of inventions allows for affection on inflammatory processes in vessels due to increase in a speed of movement of leucocytes and reduction in a number of endothelium cells exposed to adhesion.

4 cl, 9 dwg, 12 tbl, 3 ex

Similar patents RU2783498C2

Title	Year	Author	Number
TRIACETYL-3-HYDROXYPHENYLADENOSINE FOR OBTAINING PHARMACEUTICAL PREPARATIONS FOR REDUCING THE NUMBER OF MONOCYTES CIRCULATED IN THE BLOOD	2017	Zhu, Haibo Wang, Jing	RU2795163C2
PHARMACEUTICAL COMPOSITION COMPRISING microRNA-100 AND USE THEREOF IN MODULATING GROWTH OF BLOOD VESSELS AND ENDOTHELIUM INFLAMMATION	2010	Zebastian Grundmann Martin Mozer Kristof Bode Frantsiska Blum Feliks Khans	RU2586531C2
USE OF PEPTIDE FOR TREATMENT OF CARDIOVASCULAR DISEASES	2013	Gibot Sebastien Boufenzer Amir Alt-Oufella Hafid Derive Marc	RU2672341C2
USE OF TRIACETYL-3-HYDROXYPHENYLADENOSINE FOR THE PREPARATION OF PHARMACEUTICAL DRUG FOR THE PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE	2016	Zhu, Haibo Shi, Huijie	RU2759916C2
METHOD FOR DETERMINING RADIATION-INDUCED ATHEROSCLEROTIC VASCULAR DISEASE IN WORKERS EMPLOYED IN HAZARDOUS WORKING CONDITIONS AT RADIATION HAZARDOUS ENTERPRISE	2023	Oslina Darya Sergeevna Rybkina Valentina Lvovna Zhuntova Galina Vadimovna Azizova Tamara Vasilevna	RU2816338C1
4-FLUORO-N-INDANE-2-YLBENZAMIDE AND ITS USING AS PHARMACEUTICAL AGENT	2002	Vol'Fart Paulus Suzuki Teri Dkharanipragada Ramalinga M. Safarova Alena Val'Zer Armin Shtrobel' Khartmut	RU2308946C2
METHOD OF DIAGNOSING AND TREATING ENDOTHELIAL DYSFUNCTION IN METABOLIC DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE OF SECOND FUNCTIONAL CLASS	2020	Dzugkoev Sergej Gavrilovich Garmash Oksana Yurevna Dzugkoeva Fira Solomonovna	RU2737416C1
METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION WITH AZITHROMYCIN IN MODELING OF CHRONIC GRAM-POSITIVE SEPSIS	2009	Chernomortseva Elena Stanislavovna Pokrovskij Mikhail Vladimirovich Pokrovskaja Tat'Jana Grigor'Evna Artjushkova Elena Borisovna Belous Aleksandr Sergeevich Besedin Andrej Viktorovich Kalutskij Pavel Vjacheslavovich Gureev Vladimir Vladimirovich Litvjakova Evgenija Igorevna Litvjakova Marija Igorevna	RU2400826C1
NEW APPLICATION OF THERAPEUTICALLY EFFECTIVE PEPTIDES	2006	Jaukhiajnen Tiina Korpela Riitta Vapaatalo Khejkki Rennbak Mats	RU2457852C2
PEPTIDE POSSESSING ABILITY TO RELIEVE AT LEAST ONE SYMPTOM OF INFLAMMATORY CONDITION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND METHOD OF TREATING ATHEROSCLEROSIS WITH THEIR APPLICATION	2005	Anantkharamajakh Gattadakhalli M. Navab Mokhamad Fogelmehn Ehlan M.	RU2448977C2

RU 2 783 498 C2

Authors

Zhu, Haibo

Wang, Minjie

Dates

2022-11-14—Published

2017-05-23—Filed